BetterLife Pharma Short Interest Ratio and Short Volume

-0.04 (-8.02 %)
(As of 05/5/2021 03:56 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume54,104 shs
Average Volume78,954 shs
Market Capitalization$8.55 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

BetterLife Pharma (OTCMKTS:BETRF) Short Interest Data

Current Short Volume800 shares
Previous Short Volume15,500 shares
Change Vs. Previous Month-94.84%
Dollar Volume Sold Short$532.48
Short Interest Ratio / Days to Cover0.0
Last Record DateApril, 15 2021
Outstanding Shares17,211,000 shares
Percentage of Shares Shorted0.00%
Today's Trading Volume54,104 shares
Average Trading Volume78,954 shares
Today's Volume Vs. Average-31.47%

Short Interest Over Time

BetterLife Pharma (OTCMKTS:BETRF) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2021800 shares $532.48 -94.8%N/A0$0.67
3/31/202115,500 shares $14,415.00 +3,000.0%N/A0.2$0.93
3/15/2021500 shares $579.75 -61.5%N/A0$1.16
2/26/20211,300 shares $1,482.00 -83.5%N/A0$1.14
2/12/20217,900 shares $9,076.31 +172.4%N/A0.1$1.15
1/29/20212,900 shares $3,306.00 -69.2%N/A0$1.14
1/15/202113,800 shares $17,664.00 +961.5%N/A0.4$1.28
12/31/20207,900 shares $13,588.00 -42.8%N/A0$1.72
12/15/202013,800 shares $11,730.00 +961.5%N/A0.4$0.85
11/30/20201,300 shares $547.25 +62.5%N/A0$0.42
11/15/2020800 shares $373.44 -38.5%N/A0$0.47
10/30/20201,300 shares $650.00 +30.0%N/A0.1$0.50
10/15/20201,000 shares $797.00 -81.1%N/A0$0.80
9/30/20205,300 shares $4,165.80 +12.8%N/A0.4$0.79
9/15/20204,700 shares $4,607.41 -25.4%N/A0.3$0.98

BetterLife Pharma (OTCMKTS:BETRF) Short Interest FAQ

speech bubbles
speech bubbles

What is BetterLife Pharma's current short interest?

Short interest is the volume of BetterLife Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 800 shares of BETRF short.

Is BetterLife Pharma's short interest increasing or decreasing?

BetterLife Pharma saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 800 shares, a drop of 94.8% from the previous total of 15,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does BetterLife Pharma's short interest compare to its competitors?

0.00% of BetterLife Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BetterLife Pharma: Can-Fite BioPharma Ltd. (0.00%), Histogen Inc. (2.34%), Lixte Biotechnology Holdings, Inc. (0.31%), Endonovo Therapeutics, Inc. (0.00%), Hoth Therapeutics, Inc. (0.00%), Generex Biotechnology Co. (0.00%), Sonnet BioTherapeutics Holdings, Inc. (2.10%), Auris Medical Holding Ltd. (30.86%), RegeneRx Biopharmaceuticals, Inc. (0.00%), and Petros Pharmaceuticals, Inc. (1.04%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short BetterLife Pharma stock?

Short selling BETRF is an investing strategy that aims to generate trading profit from BetterLife Pharma as its price is falling. BetterLife Pharma's stock is trading down $0.04 today. To short BetterLife Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that BetterLife Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BetterLife Pharma?

A short squeeze for BetterLife Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BETRF, which in turn drives the price of the stock up even further.

How often is BetterLife Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BETRF, twice per month. The most recent reporting period available is April, 15 2021.

This page was last updated on 5/5/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.